unknown
Stage
1
Investors
About
Immunophotonics develops Interventional Immuno-Oncology® therapeutics using a proprietary glycan polymer platform designed to stimulate immune responses to fight cancer and other diseases.
Explore Immunophotonics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.